直接口服抗凝药浓度对亚洲房颤患者临床结局的影响
本研究纳入859例亚洲房颤患者,测量DOAC谷浓度和峰浓度并与临床试验预期范围比较,发现谷浓度偏低预测卒中及系统性血栓栓塞,谷浓度偏高与 major bleeding 相关,峰浓度与结局无显著关联。
要点
- 低谷浓度预测卒中/系统性血栓栓塞(HR=2.78),高谷浓度与 major bleeding 相关(HR=2.63)。
- 超说明书低剂量、每日一次给药和高肌酐清除率导致低谷浓度。
- 峰浓度与卒中或 major bleeding 无显著关联。
核心结论
- 谷浓度偏低预测卒中及系统性血栓栓塞,谷浓度偏高与 major bleeding 相关,峰浓度与结局无显著关联。
- 对存在浓度超出预期范围风险的患者,应考虑测量 DOAC 谷浓度。
研究设计与样本
- 真实世界研究,纳入年龄≥20岁、使用 DOAC≥3天的房颤患者,2016年1月至2022年7月共859例。
- 测量谷浓度和峰浓度并与临床试验预期范围比较,采用 Cox 比例风险模型分析浓度与结局的关联。
主要发现
- 859例中 dabigatran、rivaroxaban、apixaban、edoxaban 分别占22.5%、24.7%、36.4%、16.4%。
- 与临床试验相比,谷浓度高于和低于预期范围的比例分别为9.0%和14.6%,峰浓度分别为20.9%和12.1%。
- 平均随访2.4±1.6年,卒中及系统性血栓栓塞发生率为1.31/100人年,低谷浓度预测 SSE(HR=2.78(1.20, 6.46))。
- major bleeding 发生率为1.64/100人年,高谷浓度与 major bleeding 相关(HR=2.63(1.09, 6.39))。
- 超说明书低剂量(OR=2.69(1.70, 4.26))、每日一次 DOAC 给药(OR=3.22(2.07, 5.01))和高肌酐清除率(OR=1.02(1.01, 1.03))导致低谷浓度;充血性心力衰竭与高谷浓度相关(OR=1.71(1.01, 2.92))。
临床怎么用
- 对存在浓度超出预期范围风险的患者,可考虑测量 DOAC 谷浓度以指导临床决策。
- 关注超说明书低剂量、每日一次给药和高肌酐清除率等导致低谷浓度的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A real-world association between direct oral anticoagulant (DOAC) concentration and clinical outcomes among Asian patients with atrial fibrillation (AF) is reported herein. Patients with AF aged ≥ 20 years who used DOAC for ≥ 3 days were enrolled. Trough and peak DOAC concentrations were measured and compared with the expected range reported in clinical trials. The Cox proportional hazard model was used to investigate the association between concentration and outcomes. From January 2016 to July 2022, a total of 859 patients were enrolled. Among them, 22.5%, 24.7%, 36.4%, and 16.4% were on dabigatran, rivaroxaban, apixaban, and edoxaban, respectively. Compared with clinical trials, the proportion of DOAC concentrations higher or lower than the expected range were 9.0% and 14.6% for trough, respectively, and 20.9% and 12.1% for peak, respectively. The average follow-up duration was 2.4 ± 1.6 years. The incidence of stroke and systemic thromboembolism (SSE) was 1.31 per 100-person years, and low trough concentration predicted SSE (hazard ratio (HR) = 2.78 (1.20, 6.46)). The incidence of major bleeding was 1.64 per 100-person years, and high trough was associated with major bleeding (HR = 2.63 (1.09, 6.39)). The association between peak concentration and SSE or major bleeding was nonsignificant. Off-label underdosing (odds ratio (OR) = 2.69 (1.70, 4.26)), once daily DOAC dosing (OR = 3.22 (2.07, 5.01)), and high creatinine clearance (OR = 1.02 (1.01, 1.03)) caused low trough concentration. Contrarily, congestive heart failure was significantly associated with high trough concentration (OR = 1.71 (1.01, 2.92)). In conclusion, trough DOAC concentration measurements should be considered among patients at risk of out-of-expected range DOAC concentrations.
引用
- Lin SY, Tang SC, Kuo CH, et al. Impact of Direct Oral Anticoagulant Concentration on Clinical Outcomes in Asian Patients with Atrial Fibrillation. Clin Pharmacol Ther. 2023. PMID: 37132484. doi:10.1002/cpt.2927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。